Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.

Hidalgo M, Von Hoff DD.

Clin Cancer Res. 2012 Aug 15;18(16):4249-56. doi: 10.1158/1078-0432.CCR-12-1327. Review.

2.

Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?

Chandana S, Mahadevan D.

Expert Rev Mol Med. 2009 Nov 17;11:e34. doi: 10.1017/S1462399409001240.

PMID:
19919723
3.

Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment.

Rausch V, Liu L, Apel A, Rettig T, Gladkich J, Labsch S, Kallifatidis G, Kaczorowski A, Groth A, Gross W, Gebhard MM, Schemmer P, Werner J, Salnikov AV, Zentgraf H, Büchler MW, Herr I.

J Pathol. 2012 Jul;227(3):325-35. doi: 10.1002/path.3994. Epub 2012 Apr 18.

PMID:
22262369
4.

Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.

Mazur PK, Siveke JT.

Gut. 2012 Oct;61(10):1488-500. doi: 10.1136/gutjnl-2011-300756. Epub 2011 Aug 26. Review.

PMID:
21873467
5.

Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies.

Heinemann V, Reni M, Ychou M, Richel DJ, Macarulla T, Ducreux M.

Cancer Treat Rev. 2014 Feb;40(1):118-28. doi: 10.1016/j.ctrv.2013.04.004. Epub 2013 Jul 9. Review.

PMID:
23849556
6.

Biology and clinical applications of pancreatic cancer stem cells.

Abel EV, Simeone DM.

Gastroenterology. 2013 Jun;144(6):1241-8. doi: 10.1053/j.gastro.2013.01.072. Review.

PMID:
23622133
7.

[Pathogenesis of the ductal pancreatic adenocarcinoma: implications for future therapies?].

Schneider G, Schmid RM.

Internist (Berl). 2005 Feb;46(2):157-65. Review. German.

PMID:
15655682
8.

New insights into pancreatic cancer biology.

Hidalgo M.

Ann Oncol. 2012 Sep;23 Suppl 10:x135-8.

PMID:
22987949
9.

Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.

Singh P, Srinivasan R, Wig JD.

Pancreas. 2011 Jul;40(5):644-52. doi: 10.1097/MPA.0b013e31821ff741. Review.

PMID:
21673535
10.

Novel targets in pancreatic cancer research.

Kozak G, Blanco FF, Brody JR.

Semin Oncol. 2015 Feb;42(1):177-87. doi: 10.1053/j.seminoncol.2014.12.015. Epub 2014 Dec 10. Review.

PMID:
25726061
11.

Stromal biology and therapy in pancreatic cancer.

Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA, Lolkema MP, Buchholz M, Olive KP, Gress TM, Tuveson DA.

Gut. 2011 Jun;60(6):861-8. doi: 10.1136/gut.2010.226092. Epub 2010 Oct 21. Review.

PMID:
20966025
12.

Ductal pancreatic cancer in humans and mice.

Tuveson DA, Hingorani SR.

Cold Spring Harb Symp Quant Biol. 2005;70:65-72. Review.

PMID:
16869739
13.

Genomics and pharmacogenomics of pancreatic adenocarcinoma.

Lowery MA, O'Reilly EM.

Pharmacogenomics J. 2012 Feb;12(1):1-9. doi: 10.1038/tpj.2011.52. Epub 2011 Dec 20. Review.

PMID:
22186617
14.

Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?

Partensky C.

Pancreas. 2013 Jul;42(5):729-39. doi: 10.1097/MPA.0b013e318288107a. Review.

PMID:
23648843
16.

Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.

Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, Emens L, O'Reilly E, Korc M, Ellis L, Benedetti J, Rothenberg M, Willett C, Tempero M, Lowy A, Abbruzzese J, Simeone D, Hingorani S, Berlin J, Tepper J.

J Clin Oncol. 2009 Nov 20;27(33):5660-9. doi: 10.1200/JCO.2009.21.9022. Epub 2009 Oct 26. Review.

PMID:
19858397
17.

Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.

Al Haddad AH, Adrian TE.

Expert Opin Investig Drugs. 2014 Nov;23(11):1499-515. doi: 10.1517/13543784.2014.933206. Epub 2014 Jul 31. Review.

PMID:
25078674
18.

Immuno- and gene-therapeutic strategies targeted against cancer (mainly focusing on pancreatic cancer).

Yoshimura K, Olino K, Edil BH, Schulick RD, Oka M.

Surg Today. 2010 May;40(5):404-10. doi: 10.1007/s00595-009-4120-8. Epub 2010 Apr 28. Review.

PMID:
20425541
19.

Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts.

Kruger S, Haas M, Ormanns S, Bächmann S, Siveke JT, Kirchner T, Heinemann V, Boeck S.

World J Gastroenterol. 2014 Aug 21;20(31):10769-77. doi: 10.3748/wjg.v20.i31.10769. Review.

20.

Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma.

Vizio B, Mauri FA, Prati A, Trivedi P, Giacobino A, Novarino A, Satolli MA, Ciuffreda L, Camandona M, Gasparri G, Bellone G.

Oncol Rep. 2012 Jan;27(1):69-76. doi: 10.3892/or.2011.1461. Epub 2011 Sep 14.

PMID:
21922151

Supplemental Content

Support Center